Projected Stock Price
No data available.
Projected Revenue
No data available.
Projected Earnings Per Share
Estimated quarterly earnings by December 31, 2027.
Price Target
No data available.
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for CME Group Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
In addition to being able to interpret financial data, stock analysts have connections within the companies they cover that give them access to information retail investors do not have.
Therefore, analyst ratings can help you find opportunities in the market. However, they are guidelines more than recommendations. This is why it’s important to look at analyst ratings over a period of time.
If analysts change their ratings frequently, you should pay close attention to the company’s fundamentals. For example, has there been a significant change to the company’s earnings growth and/or debt?
You should also pay attention to the number of analysts covering a stock over the course of a year. In general, the more analysts who cover the stock give the consensus rating more credibility, but each individual rating less overall weight.
Analyst ratings are one data point for you to consider. Here are some strategies you can use to fine tune your research.
Look at more than one analyst and don’t hesitate to look at analysts that have differing views. This can help challenge any preconceived ideas you have about a stock and point out ways in which your thesis for owning or avoiding a stock may have changed.
Compare a stock’s rating with other stocks in its industry or sector. In some cases, a stock is simply superior to others in its sector. However, at other times, it could be overvalued based on investor sentiment instead of fundamentals.
How are the Fintel Analyst Ratings different?Analyst ratings by Fintel are presented in close to real-time to stay ahead of generalized information flow. Combined with target price estimates and revenue estimates for the company you have greater accuracy despite market volatility.
Date | Analyst | Prior | Latest Recommendation |
Action |
---|---|---|---|---|
2025-06-04 | Oppenheimer | Outperform | Outperform | Maintains |
2025-04-25 | UBS | Buy | Buy | Maintains |
2025-04-24 | JP Morgan | Underweight | Underweight | Maintains |
2025-04-24 | Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintains |
2025-04-24 | Morgan Stanley | Overweight | Overweight | Maintains |
2025-04-23 | Barclays | Equal-Weight | Equal-Weight | Maintains |
2025-04-11 | Oppenheimer | Outperform | Outperform | Maintains |
2025-04-08 | Piper Sandler | Overweight | Overweight | Maintains |
2025-04-07 | Barclays | Equal-Weight | Equal-Weight | Maintains |
2025-04-03 | RBC Capital | Sector Perform | Sector Perform | Reiterate |
2025-04-02 | B of A Securities | Underperform | Underperform | Maintains |
2025-03-10 | Raymond James | Market Perform | Outperform | Upgrade |
2025-02-19 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
2025-02-14 | Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintains |
2025-02-13 | JP Morgan | Underweight | Underweight | Maintains |
2025-02-13 | Oppenheimer | Outperform | Outperform | Maintains |
2025-02-13 | RBC Capital | Sector Perform | Sector Perform | Maintains |
2025-02-13 | Barclays | Equal-Weight | Equal-Weight | Maintains |
2025-01-13 | Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintains |
2025-01-07 | Piper Sandler | Overweight | Overweight | Maintains |
2025-01-06 | RBC Capital | Sector Perform | Sector Perform | Reiterate |
2025-01-06 | Citigroup | Buy | Neutral | Downgrade |
2024-12-20 | Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintains |
2024-12-09 | Barclays | Equal-Weight | Equal-Weight | Maintains |
2024-11-11 | Deutsche Bank | Hold | Hold | Maintains |
2024-10-28 | Piper Sandler | Overweight | Overweight | Maintains |
2024-10-24 | RBC Capital | Sector Perform | Sector Perform | Reiterate |
2024-10-24 | Oppenheimer | Outperform | Outperform | Maintains |
2024-10-24 | Citigroup | Buy | Buy | Maintains |
2024-10-24 | Barclays | Equal-Weight | Equal-Weight | Maintains |
2024-10-17 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
2024-10-14 | Oppenheimer | Outperform | Outperform | Maintains |
2024-10-08 | Redburn Atlantic | Buy | Neutral | Downgrade |
2024-10-08 | Piper Sandler | Overweight | Overweight | Maintains |
2024-10-07 | Barclays | Equal-Weight | Equal-Weight | Maintains |
2024-10-03 | Goldman Sachs | Sell | Sell | Maintains |
2024-10-03 | Citigroup | Buy | Buy | Maintains |
2024-10-03 | RBC Capital | Sector Perform | Sector Perform | Reiterate |
2024-10-03 | B of A Securities | Underperform | Underperform | Maintains |
2024-09-27 | RBC Capital | Sector Perform | Initiate | |
2024-09-26 | TD Cowen | Hold | Initiate | |
2024-09-03 | B of A Securities | Neutral | Underperform | Downgrade |
2024-08-20 | Piper Sandler | Overweight | Overweight | Reiterate |
2024-08-15 | Deutsche Bank | Hold | Hold | Maintains |
2024-07-25 | Deutsche Bank | Hold | Hold | Maintains |
2024-07-25 | Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintains |
2024-07-25 | JP Morgan | Underweight | Underweight | Maintains |
2024-07-25 | Barclays | Equal-Weight | Equal-Weight | Maintains |
2024-07-25 | Piper Sandler | Overweight | Overweight | Maintains |
2024-07-10 | Barclays | Equal-Weight | Equal-Weight | Maintains |
2024-07-09 | Piper Sandler | Overweight | Overweight | Maintains |
2024-07-03 | Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintains |
2024-06-21 | JP Morgan | Neutral | Underweight | Downgrade |
2024-04-25 | JP Morgan | Neutral | Neutral | Maintains |
2024-04-25 | B of A Securities | Neutral | Neutral | Maintains |
2024-04-25 | Barclays | Equal-Weight | Equal-Weight | Maintains |
2024-04-25 | Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintains |
2024-04-25 | Rosenblatt | Sell | Sell | Reiterate |
2024-04-09 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
2024-04-08 | Barclays | Equal-Weight | Equal-Weight | Maintains |
2024-04-05 | Deutsche Bank | Buy | Hold | Downgrade |
2024-04-03 | Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintains |
2024-03-06 | Argus Research | Buy | Buy | Maintains |
2024-02-15 | Barclays | Equal-Weight | Equal-Weight | Maintains |
2024-01-08 | Barclays | Overweight | Equal-Weight | Downgrade |
2024-01-04 | Rosenblatt | Sell | Sell | Reiterate |
2024-01-03 | Goldman Sachs | Neutral | Sell | Downgrade |
2023-10-26 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
2023-10-26 | Rosenblatt | Sell | Sell | Maintains |
2023-10-26 | Barclays | Overweight | Overweight | Maintains |
2023-10-12 | Citigroup | Buy | Buy | Maintains |
2023-10-11 | JP Morgan | Neutral | Neutral | Maintains |
2023-10-11 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
2023-10-11 | Deutsche Bank | Buy | Buy | Maintains |
2023-10-10 | Barclays | Overweight | Overweight | Maintains |
2023-10-04 | Rosenblatt | Sell | Sell | Reiterate |
2023-09-06 | B of A Securities | Underperform | Neutral | Upgrade |
2023-07-27 | Citigroup | Buy | Buy | Maintains |
2023-07-27 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
2023-07-27 | Oppenheimer | Outperform | Outperform | Reiterate |
2023-07-27 | Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintains |
2023-07-27 | Barclays | Overweight | Overweight | Maintains |
2023-07-27 | Rosenblatt | Sell | Sell | Maintains |
2023-07-13 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
2023-07-06 | Citigroup | Buy | Buy | Reiterate |
2023-07-06 | Rosenblatt | Sell | Sell | Maintains |
2023-06-28 | Barclays | Overweight | Initiate | |
2023-04-19 | JP Morgan | Neutral | Maintains | |
2023-04-12 | Oppenheimer | Outperform | Maintains | |
2023-04-11 | Morgan Stanley | Equal-Weight | Maintains | |
2023-04-05 | Rosenblatt | Sell | Reiterate | |
2023-02-13 | Morgan Stanley | Equal-Weight | Maintains | |
2023-02-09 | Credit Suisse | Outperform | Maintains | |
2023-02-09 | Rosenblatt | Sell | Reiterate | |
2023-02-07 | Credit Suisse | Outperform | Maintains | |
2023-01-19 | Oppenheimer | Outperform | Maintains | |
2023-01-11 | Morgan Stanley | Equal-Weight | Maintains | |
2023-01-05 | Credit Suisse | Neutral | Outperform | Upgrade |
2022-12-19 | Piper Sandler | Overweight | Maintains | |
2022-10-27 | Morgan Stanley | Equal-Weight | Maintains | |
2022-10-12 | Deutsche Bank | Hold | Buy | Upgrade |
2022-10-12 | Morgan Stanley | Equal-Weight | Maintains | |
2022-10-12 | Citigroup | Buy | Initiate | |
2022-10-05 | Rosenblatt | Sell | Maintains | |
2022-09-06 | Credit Suisse | Neutral | Maintains | |
2022-08-17 | Rosenblatt | Sell | Initiate | |
2022-08-15 | Raymond James | Outperform | Market Perform | Downgrade |
2022-08-12 | Deutsche Bank | Hold | Maintains | |
2022-08-03 | Credit Suisse | Neutral | Maintains | |
2022-08-02 | UBS | Buy | Maintains | |
2022-07-28 | Morgan Stanley | Equal-Weight | Maintains | |
2022-07-28 | Credit Suisse | Neutral | Maintains | |
2022-07-19 | Morgan Stanley | Equal-Weight | Maintains | |
2022-07-13 | Deutsche Bank | Hold | Maintains | |
2022-07-06 | Raymond James | Outperform | Maintains | |
2022-07-06 | UBS | Buy | Maintains | |
2022-07-06 | Credit Suisse | Neutral | Maintains | |
2022-06-10 | Atlantic Equities | Neutral | Overweight | Upgrade |
2022-06-03 | UBS | Buy | Maintains | |
2022-05-25 | Oppenheimer | Perform | Outperform | Upgrade |
2022-05-19 | Deutsche Bank | Hold | Maintains | |
2022-05-16 | Argus Research | Hold | Buy | Upgrade |
2022-04-28 | Credit Suisse | Neutral | Maintains | |
2022-04-28 | Citigroup | Buy | Maintains | |
2022-04-28 | Rosenblatt | Neutral | Maintains | |
2022-04-28 | Raymond James | Outperform | Maintains | |
2022-04-14 | Rosenblatt | Neutral | Maintains | |
2022-04-13 | Morgan Stanley | Equal-Weight | Maintains | |
2022-04-05 | Credit Suisse | Neutral | Maintains | |
2022-03-08 | Rosenblatt | Neutral | Maintains | |
2022-03-03 | UBS | Buy | Maintains | |
2022-03-03 | Credit Suisse | Neutral | Maintains | |
2022-02-15 | Credit Suisse | Neutral | Initiate | |
2022-02-11 | Morgan Stanley | Equal-Weight | Maintains | |
2022-02-10 | Raymond James | Outperform | Maintains | |
2022-02-08 | Atlantic Equities | Overweight | Neutral | Downgrade |
2022-01-20 | Rosenblatt | Sell | Neutral | Upgrade |
2022-01-05 | Raymond James | Outperform | Maintains | |
2021-10-28 | Morgan Stanley | Equal-Weight | Maintains | |
2021-10-28 | Rosenblatt | Sell | Maintains | |
2021-10-28 | Raymond James | Outperform | Maintains | |
2021-10-08 | Morgan Stanley | Equal-Weight | Maintains | |
2021-07-01 | Morgan Stanley | Equal-Weight | Maintains | |
2021-06-14 | Morgan Stanley | Equal-Weight | Initiate | |
2021-06-11 | Morgan Stanley | Equal-Weight | Initiate | |
2021-06-10 | Atlantic Equities | Overweight | Neutral | Downgrade |
2021-04-30 | Argus Research | Buy | Hold | Downgrade |
2021-04-29 | Citigroup | Buy | Maintains | |
2021-04-20 | Citigroup | Buy | Maintains | |
2021-03-24 | B of A Securities | Neutral | Buy | Upgrade |
2021-02-25 | Wells Fargo | Equal-Weight | Overweight | Upgrade |
2021-02-11 | Citigroup | Buy | Maintains | |
2021-01-15 | Oppenheimer | Outperform | Perform | Downgrade |
2021-01-08 | Deutsche bank | Buy | Hold | Downgrade |
2021-01-07 | JP Morgan | Underweight | Neutral | Upgrade |
2021-01-06 | Rosenblatt | Sell | Maintains | |
2020-12-03 | Rosenblatt | Sell | Maintains | |
2020-11-04 | Rosenblatt | Sell | Maintains | |
2020-10-29 | Deutsche Bank | Buy | Maintains | |
2020-10-05 | Rosenblatt | Sell | Maintains | |
2020-09-23 | Atlantic Equities | Neutral | Overweight | Upgrade |
2020-09-10 | Credit Suisse | Neutral | Maintains | |
2020-07-30 | Deutsche Bank | Buy | Maintains | |
2020-07-30 | Rosenblatt | Sell | Maintains | |
2020-07-13 | Oppenheimer | Outperform | Maintains | |
2020-07-10 | B of A Securities | Neutral | Maintains | |
2020-07-09 | Deutsche Bank | Buy | Maintains | |
2020-06-23 | Credit Suisse | Neutral | Maintains | |
2020-06-03 | Rosenblatt | Sell | Maintains | |
2020-05-15 | Deutsche Bank | Buy | Maintains | |
2020-04-30 | Wells Fargo | Equal-Weight | Maintains | |
2020-04-30 | UBS | Buy | Maintains | |
2020-04-29 | CFRA | Hold | Maintains | |
2020-04-20 | Citigroup | Buy | Maintains | |
2020-04-14 | Keefe, Bruyette & Woods | Market Perform | Underperform | Downgrade |
2020-04-13 | Oppenheimer | Outperform | Maintains | |
2020-04-09 | Deutsche Bank | Buy | Maintains | |
2020-04-03 | UBS | Buy | Maintains | |
2020-04-03 | Citigroup | Buy | Maintains | |
2020-03-31 | Deutsche Bank | Buy | Maintains | |
2020-03-30 | Raymond James | Market Perform | Outperform | Upgrade |
2020-03-23 | B of A Securities | Neutral | Maintains | |
2020-03-18 | Deutsche Bank | Buy | Maintains | |
2020-03-05 | Deutsche Bank | Buy | Maintains | |
2020-02-26 | UBS | Neutral | Buy | Upgrade |
2020-02-13 | CFRA | Hold | Maintains | |
2019-12-19 | Deutsche Bank | Buy | Maintains | |
2019-12-16 | Credit Suisse | Neutral | Initiate | |
2019-12-06 | JP Morgan | Underweight | Maintains | |
2019-12-04 | UBS | Neutral | Maintains | |
2019-11-27 | Deutsche Bank | Buy | Maintains | |
2019-10-31 | UBS | Neutral | Maintains | |
2019-10-31 | Wells Fargo | Market Perform | Maintains | |
2019-10-21 | Citigroup | Buy | Maintains | |
2019-10-03 | UBS | Neutral | Maintains | |
2019-09-19 | Berenberg | Buy | Hold | Downgrade |
2019-09-17 | Oppenheimer | Outperform | Initiate | |
2019-09-05 | UBS | Neutral | Maintains | |
2019-08-09 | Deutsche Bank | Buy | Maintains | |
2019-07-03 | Wells Fargo | Market Perform | Maintains | |
2019-07-03 | UBS | Neutral | Maintains | |
2019-06-05 | UBS | Neutral | Maintains | |
2019-05-02 | UBS | Neutral | Neutral | Maintains |
2019-04-18 | Rosenblatt | Neutral | Sell | Downgrade |
2019-03-26 | Barclays | Overweight | Overweight | Maintains |
2019-03-15 | Deutsche Bank | Buy | Buy | Maintains |
2019-02-15 | JP Morgan | Neutral | Underweight | Downgrade |
2019-01-11 | Bank of America | Buy | Neutral | Downgrade |
2018-11-28 | Atlantic Equities | Neutral | Initiate | |
2018-11-28 | UBS | Buy | Neutral | Downgrade |
2018-11-20 | Berenberg | Hold | Buy | Upgrade |
2018-11-20 | Citigroup | Buy | Buy | Maintains |
2018-11-16 | Deutsche Bank | Buy | Buy | Maintains |
2018-10-26 | Wells Fargo | Market Perform | Market Perform | Maintains |
2018-10-11 | Deutsche Bank | Buy | Buy | Maintains |
2018-09-05 | Rosenblatt | Neutral | Initiate | |
2018-07-10 | Compass Point | Neutral | Initiate | |
2018-04-10 | Bernstein | Outperform | Initiate | |
2018-04-06 | Deutsche Bank | Buy | Buy | Maintains |
2018-03-08 | Bank of America | Buy | Buy | Maintains |
2018-02-02 | Barclays | Overweight | Overweight | Maintains |
2018-02-02 | Bank of America | Buy | Buy | Maintains |
2018-01-25 | Berenberg | Hold | Initiate | |
2017-10-19 | Citigroup | Buy | Maintains | |
2017-10-10 | Barclays | Overweight | Maintains | |
2017-10-04 | Wells Fargo | Market Perform | Maintains | |
2017-09-08 | Barclays | Overweight | Initiate | |
2017-09-06 | UBS | Buy | Maintains | |
2017-07-17 | Jefferies | Buy | Maintains | |
2017-07-12 | Citigroup | Buy | Initiate | |
2016-11-14 | JP Morgan | Overweight | Neutral | Downgrade |
2016-10-05 | Deutsche Bank | Buy | Maintains | |
2016-08-31 | Jefferies | Buy | Maintains | |
2016-08-05 | Deutsche Bank | Buy | Maintains | |
2016-07-29 | Keefe Bruyette & Woods | Market Perform | Maintains | |
2016-07-29 | Barclays | Equal-Weight | Maintains | |
2016-07-29 | Deutsche Bank | Buy | Maintains | |
2016-07-29 | JP Morgan | Overweight | Maintains | |
2016-07-29 | UBS | Buy | Maintains | |
2016-07-14 | CLSA | Underperform | Maintains | |
2016-05-20 | Sterne Agee CRT | Neutral | Initiate | |
2016-05-03 | Buckingham Research | Buy | Initiate | |
2016-04-08 | Keefe Bruyette & Woods | Market Perform | Maintains | |
2016-03-11 | JP Morgan | Neutral | Maintains | |
2016-02-09 | Deutsche Bank | Buy | Maintains | |
2016-02-08 | Keefe Bruyette & Woods | Market Perform | Maintains | |
2016-01-26 | Deutsche Bank | Buy | Maintains | |
2016-01-13 | JP Morgan | Neutral | Overweight | Upgrade |
2016-01-06 | Credit Suisse | Neutral | Maintains | |
2015-12-08 | RBC Capital | Underperform | Initiate | |
2015-10-30 | Barclays | Equal-Weight | Maintains | |
2015-10-08 | Keefe Bruyette & Woods | Market Perform | Maintains | |
2015-09-04 | JP Morgan | Neutral | Maintains | |
2015-08-11 | Barclays | Equal-Weight | Maintains | |
2015-07-31 | Keefe Bruyette & Woods | Market Perform | Maintains | |
2015-07-10 | Barclays | Equal-Weight | Maintains | |
2015-07-06 | UBS | Buy | Maintains | |
2015-06-17 | Keefe Bruyette & Woods | Market Perform | Maintains | |
2015-06-05 | JP Morgan | Neutral | Maintains | |
2015-05-08 | Evercore ISI Group | Hold | Buy | Upgrade |
2015-05-08 | Deutsche Bank | Buy | Maintains | |
2015-05-08 | Barclays | Equal-Weight | Maintains | |
2015-05-01 | Barclays | Equal-Weight | Maintains | |
2015-04-10 | Barclays | Equal-Weight | Maintains | |
2015-03-30 | Jefferies | Buy | Maintains | |
2015-03-06 | Deutsche Bank | Buy | Maintains | |
2015-02-06 | Deutsche Bank | Buy | Maintains | |
2015-02-06 | Citigroup | Buy | Maintains | |
2015-01-23 | Deutsche Bank | Buy | Maintains | |
2015-01-20 | Citigroup | Neutral | Buy | Upgrade |
2015-01-07 | Jefferies | Buy | Maintains | |
2015-01-07 | CLSA | Outperform | Underperform | Downgrade |
2014-12-12 | Deutsche Bank | Buy | Maintains | |
2014-12-08 | Keefe, Bruyette & Woods | Outperform | Market Perform | Downgrade |
2014-10-31 | Citigroup | Neutral | Maintains | |
2014-10-14 | Deutsche Bank | Buy | Maintains | |
2014-10-08 | Bank of America | Neutral | Maintains | |
2014-10-07 | Citigroup | Neutral | Maintains | |
2014-10-02 | Credit Suisse | Neutral | Maintains | |
2014-09-18 | Keefe Bruyette & Woods | Outperform | Maintains | |
2014-09-10 | Deutsche Bank | Buy | Initiate | |
2014-08-01 | Barclays | Equal-Weight | Maintains | |
2014-07-08 | JP Morgan | Neutral | Maintains | |
2014-06-30 | Barclays | Equal-Weight | Maintains | |
2014-06-10 | JP Morgan | Neutral | Maintains | |
2014-05-09 | Jefferies | Buy | Maintains | |
2014-05-06 | JP Morgan | Neutral | Maintains | |
2014-05-02 | Barclays | Equal-Weight | Maintains | |
2014-05-02 | UBS | Buy | Maintains | |
2014-05-02 | Citigroup | Hold | Maintains | |
2014-04-10 | Citigroup | Neutral | Maintains | |
2014-04-09 | Citigroup | Neutral | Maintains | |
2014-01-28 | JP Morgan | Neutral | Maintains | |
2014-01-08 | Citigroup | Buy | Neutral | Downgrade |
2013-10-21 | Compass Point | Neutral | Maintains | |
2013-09-25 | Keefe Bruyette & Woods | Market Perform | Outperform | Upgrade |
2013-08-02 | UBS | Buy | Maintains | |
2013-07-02 | Raymond James | Outperform | Market Perform | Downgrade |
2013-06-25 | JP Morgan | Underweight | Neutral | Upgrade |
2013-06-24 | Goldman Sachs | Sell | Neutral | Upgrade |
2013-06-14 | ISI Group | Neutral | Buy | Upgrade |
2013-06-04 | Wells Fargo | Market Perform | Outperform | Upgrade |
2013-06-03 | Jefferies | Buy | Maintains | |
2013-05-31 | Keefe Bruyette & Woods | Underperform | Market Perform | Upgrade |
2013-05-21 | Macquarie | Outperform | Neutral | Downgrade |
2013-05-03 | Compass Point | Neutral | Maintains | |
2013-04-15 | Jefferies | Buy | Maintains | |
2013-04-02 | Credit Suisse | Overweight | Neutral | Downgrade |
2013-03-05 | JP Morgan | Underweight | Maintains | |
2013-01-09 | Compass Point | Neutral | Initiate | |
2012-12-14 | Keefe Bruyette & Woods | Market Perform | Underperform | Downgrade |
2012-12-10 | Goldman Sachs | Neutral | Sell | Downgrade |
2012-10-26 | BGB Securities | Hold | Maintains | |
2012-10-26 | UBS | Buy | Maintains | |
2012-10-26 | Evercore Partners | Overweight | Equal-Weight | Downgrade |
2012-10-26 | Raymond James | Market Perform | Outperform | Upgrade |
2012-10-08 | Stifel Nicolaus | Buy | Hold | Downgrade |
2012-10-03 | JP Morgan | Underweight | Maintains | |
2012-10-01 | Jefferies | Buy | Maintains | |
2012-09-14 | JP Morgan | Neutral | Underweight | Downgrade |
2012-08-17 | UBS | Neutral | Maintains | |
2012-06-21 | BGB Securities | Hold | Initiate | |
2012-04-27 | UBS | Buy | Maintains | |
2012-04-27 | ISI Group | Hold | Maintains | |
2012-04-27 | JP Morgan | Neutral | Maintains | |
2012-04-27 | Jefferies | Buy | Maintains | |
2012-04-12 | Indaba Global Research | Sell | Initiate | |
2012-04-04 | Jefferies | Buy | Maintains | |
2012-04-03 | Deutsche Bank | Hold | Maintains | |
2012-03-20 | UBS | Buy | Maintains | |
2012-03-16 | Deutsche Bank | Hold | Maintains | |
2012-03-05 | Evercore Partners | Equal-Weight | Maintains | |
2012-03-02 | Stifel Nicolaus | Buy | Maintains | |
2025-07-24 | Oppenheimer | Outperform | Outperform | Maintains |
2025-07-24 | UBS | Buy | Neutral | Downgrade |
2025-07-24 | Barclays | Equal-Weight | Equal-Weight | Maintains |
2025-07-03 | Citigroup | Neutral | Neutral | Maintains |
2025-07-10 | Barclays | Equal-Weight | Equal-Weight | Maintains |
2025-07-15 | Piper Sandler | Overweight | Overweight | Maintains |
Revenue Estimates
No data available.
Earnings Estimates
The forecasted annual earnings of CME Group Inc. in 2029-12-31 is 14.44 per share.
One part of an analyst’s rating is a profit (i.e., earnings) estimate for the current quarter and/or future quarters. The measurement given is earnings per share (EPS). EPS is a metric that indicates how much a company earned as represented by one share of its stock over a specific period (typically three months).
To understand the earnings per share calculation, you must understand net income. Net income is the amount of money a company has left over after deducting appropriate expenses and taxes from its revenues).
The formula for earnings per share is net income divided by the total number of outstanding shares (i.e., available for purchase). For example:
Company A has a net income of $100 million and forty million outstanding shares. The EPS calculation is as follows:
100,000,000/40,000,000 = $2.50 per share
Earnings per share is an essential metric for you to consider when deciding to buy a stock. After all, a company with high earnings per share is productive and generates revenue in excess of its operating costs.
However, it’s not the only metric you should use. Metrics like price-to-earnings and debt-to-equity add additional perspective about a company’s health.
You should also be sure to compare a company’s EPS with a company in its sector. However, when you do, be aware that EPS is different and more important than net profit by itself. You may see a company that has a rising net profit. But if its outstanding shares are also rising, then its EPS might be flat or even edging lower.
Update Frequency: Quarterly
Date | EPS Average (Quarterly) | Number of Analysts (Quarterly) | EPS Average (Annual) | Number of Analysts (Annually) |
---|---|---|---|---|
2025-09-30 | 2.74 | 16 | -- | -- |
2025-12-31 | 2.64 | 16 | 11.08 | 19 |
2026-03-31 | 2.76 | 10 | -- | -- |
2026-06-30 | 2.80 | 10 | -- | -- |
2026-09-30 | 2.85 | 10 | -- | -- |
2026-12-31 | 2.76 | 10 | 11.62 | 19 |
2027-03-31 | 3.21 | 5 | -- | -- |
2027-06-30 | 3.26 | 5 | -- | -- |
2027-09-30 | 3.07 | 5 | -- | -- |
2027-12-31 | 2.99 | 5 | 12.47 | 12 |
2028-12-31 | -- | -- | 13.38 | 2 |
2029-12-31 | -- | -- | 14.44 | 2 |